VIVOS THERAPEUTICS INC - COM (VVOS)

CUSIP: 92859E108

Q3 2023 13F Holders as of 30 Sep 2023

Share change
-284,665
SEC-reported price per share
$0.28
Number of holders
5
Value change
-$143,428
Number of sells
9

Security key

92859E108

Report period

Q3 2023

Institutions

5

Top holders

5

Ownership snapshot

Top reported holders of VVOS - VIVOS THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gurdev Dave Singh
Disclosed value leader
Gurdev Dave Singh
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5 13F Highest disclosed value: $1,728,844 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Gurdev Dave Singh has the largest disclosed position value at $1.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gurdev Dave Singh's linked filing trail.
Disclosed position value Top 5
Gurdev Dave Singh $1.73M
Strategic Wealth Investment Group... $1.64M
VANGUARD GROUP INC $364.2K
GEODE CAPITAL MANAGEMENT, LLC $103K
GODSEY & GIBB, INC $47.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gurdev Dave Singh
3/4/5
Chief Medical Officer, Director, 10%+ Owner
—
mixed-class rows
$1,728,844
3,266,372 shares
mixed-class rows
— 05 Aug 2021
Strategic Wealth Investment Group, LLC
13F
Company
13F
—
denominator unverified
$1,642,050
3,219,705 shares
— 30 Jun 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$364,194
714,106 shares
— 30 Jun 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$102,989
201,941 shares
— 30 Jun 2023
GODSEY & GIBB, INC
13F
Company
13F
—
denominator unverified
$47,430
92,999 shares
— 30 Jun 2023
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$32,284
63,301 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
5
Shares
61,442
Rows available
5
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
28
Q3 2023 holders
5
Holder diff
-23
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .